Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada

Newborn screening (NBS) for spinal muscular atrophy (SMA) and reimbursement of disease-modifying therapies (DMTs) are managed provincially in Canada, creating inequities in diagnosis and treatment. We describe NBS methodology, reporting practices, and DMT reimbursement across Canada and report the first national birth prevalence of SMA.

Authors

Institutions

Publication Details

Journal
Neurology Genetics
Published
2026-10-15
DOI
https://doi.org/10.1212/nxg.0000000000200451
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada

Homira Osman, Kristin D. Kernohan, Kathryn A. Selby, Andrew Muranyi et al.
Neurology Genetics
Neurogenetic and Muscular Disorders Research
article

Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada

Homira Osman, Kristin D. Kernohan, Kathryn A. Selby, Andrew Muranyi, Nick A. Antonishyn, Graham B. Sinclair, Maryam Oskoui, Yves Giguère, Stacey L. Hume, Paul G. Van Caeseele, Hugh J. McMillan, Melanie Lacaria, Zaiping Liu, Cherie Evans
article en

Abstract

Newborn screening (NBS) for spinal muscular atrophy (SMA) and reimbursement of disease-modifying therapies (DMTs) are managed provincially in Canada, creating inequities in diagnosis and treatment. We describe NBS methodology, reporting practices, and DMT reimbursement across Canada and report the first national birth prevalence of SMA.

Neurology GeneticsVol. 12(6)
Dalhousie University (CA), Children's Hospital of Eastern Ontario (CA), Saskatchewan Health (CA), Muscular Dystrophy Canada (CA), Alberta Hospital Edmonton (CA), Centre Hospitalier Universitaire Sainte-Justine (CA), Nova Scotia Health Authority (CA), University of Alberta Hospital (CA), BC Children's Hospital (CA), Université Laval (CA), Cadham Provincial Laboratory (CA), Université de Montréal (CA)
Biogen, Sarepta Therapeutics
Good health and well-being
Openalex Percentile: Top 14%
Neurogenetic and Muscular Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.